Pharma channel feed

US de­clares mon­key­pox a na­tion­al health emer­gency, as new drug­mak­ers con­sid­er en­ter­ing vac­cine race

3 years ago
R&D
Manufacturing

Bio­haven touts surge in Nurtec sales ahead of Pfiz­er takeover

3 years ago

AARP push­es for Medicare ne­go­ti­a­tions in TV ad as Con­gress tees up drug pric­ing leg­is­la­tion vote

3 years ago
Marketing

Phar­ma brands chill in the phar­ma­cy re­tail aisle with new style ads on re­frig­er­a­tion screens

3 years ago
Marketing

De­moc­rats se­cure sup­port from key sen­a­tor ahead of po­ten­tial drug pric­ing vote

3 years ago
FDA+

Aca­dia hits an­oth­er Nu­plazid road­block as the FDA doles out CRL and rec­om­mends an­oth­er tri­al

3 years ago
FDA+

Am­gen diss­es drug pric­ing bill, while amp­ing $4B rare drug com­pa­ny deal and up­com­ing Hu­mi­ra biosim launch

3 years ago
Marketing

Pros­e­cu­tors fail to ex­tend ex-GSK sci­en­tist­s' sen­tences in trade se­crets case

3 years ago
Law

Bay­er CEO Wern­er Bau­mann says com­pa­ny is 'putting ma­jor lit­i­ga­tion be­hind us' while high­light­ing Q2 growth

3 years ago

Bris­tol My­er­s' on­line ini­tia­tive ad­vo­cates work sup­port for MS pa­tients and care­givers

3 years ago
Marketing

Eli Lil­ly CEO Ricks echoes a grow­ing re­frain on price ne­go­ti­a­tions: 'We’ll fo­cus our re­sources on oth­er ar­eas'

3 years ago

Green­Light Bio­sciences cel­e­brates man­u­fac­tur­ing mile­stone for Covid-19 boost­er can­di­date

3 years ago
Coronavirus
Manufacturing

Weeks af­ter start­ing, Am­gen flash­es yel­low light on PhI­II of $400M eczema bet

3 years ago
R&D

Pfiz­er ter­mi­nates PhI­II study of rare car­dio­vas­cu­lar drug picked up in $11.4B Ar­ray ac­qui­si­tion

3 years ago
R&D

Co­herus pulls first in­ter­change­able biosim­i­lar win for Lu­cen­tis copy­cat

3 years ago
FDA+

Hori­zon low­ers ex­pec­ta­tions for Te­pez­za and ad­justs its strat­e­gy for the year ahead

3 years ago
R&D

Sales of Boehringer In­gel­heim's di­a­betes, pul­monary drugs jump with­in $11B+ first-half to­tal

3 years ago

Mod­er­na CEO Ban­cel hits the gas with vari­ant-spe­cif­ic boost­ers and a very ear­ly mon­key­pox pro­gram un­der­way

3 years ago

Drug pro­mo­tion en­force­ment so far sim­i­lar un­der new FDA chief, with just 4 let­ters in first half of 2022

3 years ago
FDA+
Marketing

George Yan­copou­los says he's on the trail of the holy grail: ‘This could rep­re­sent the next break­through for im­munother­a­py’

3 years ago
Bioregnum

Al­ny­lam her­alds PhI­II APOL­LO-B win on way to cre­at­ing an ‘in­dus­try lead­ing TTR fran­chise’

3 years ago
R&D

Gilead re­ports 'very strong quar­ter' de­spite slip­ping Vek­lury sales

3 years ago

Cu­ria nets con­tract for cannabi­noid can­di­date and taps a new pres­i­dent of man­u­fac­tur­ing

3 years ago
People
Manufacturing

'What’s wrong with hav­ing lots of patents?' Fed­er­al ap­peals judge sides with Ab­b­Vie in Hu­mi­ra case

3 years ago
Law
First page Previous page 182183184185186187188 Next page Last page
A service from the Financial Times